financetom
Personal Finance
financetom
/
Personal Finance
/
Research Alert: CFRA Lowers Opinion On Shares Of Silgan Holdings Inc. To Buy From Strong Buy
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Research Alert: CFRA Lowers Opinion On Shares Of Silgan Holdings Inc. To Buy From Strong Buy
Jul 30, 2025 12:33 PM

03:05 PM EDT, 07/30/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We lower our 12-month target price by $11 to $51 on an EV/EBITDA of 8.8x our 2026 estimate, a discount to SLGN's five-year average of 9.0x reflecting higher debt levels than our previous assumptions. Leverage (net debt/LTM adjusted EBITDA) increased from 4.7x in Q1 to 5.0x in Q2, significantly above the peer average of 4.0x. We forecast leverage declining to 4.2x for 2025 and 3.7x for 2026, dependent on full allocation of FCF toward debt repayment, which we estimate at $430 million and $450 million, respectively. Underperformance on FCF generation could significantly impact valuation. While the company achieved record Q2 2025 performance and successfully integrated the Weener acquisition ahead of schedule, issues in North American beverages and a customer bankruptcy in metal containers led management to revise full-year 2025 adjusted EPS guidance lower to $3.85-$4.05 from the prior $4.00-$4.20 range. We lower our 2025 EPS estimate by $0.18 to $4.01 and 2026 by $0.13 to $4.40 and downgrade our rating to Buy.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Research Alert: CFRA Maintains Sell Opinion On Shares Of Virgin Galactic Holdings, Inc.
Research Alert: CFRA Maintains Sell Opinion On Shares Of Virgin Galactic Holdings, Inc.
Aug 9, 2025
01:05 PM EDT, 08/09/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We keep our 12-month target price at $3, applying an EV/revenue multiple of 0.7x to our 2026 estimate, a slight discount to peers, reflecting cash burn and delays to its...
Research Alert: CFRA Keeps Hold Opinion On Shares Of Markel Group, Inc.
Research Alert: CFRA Keeps Hold Opinion On Shares Of Markel Group, Inc.
Aug 10, 2025
01:05 AM EDT, 08/11/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We keep our $2,000 target price, based on 18.8x our 2026 operating EPS estimate of $106.15 (cut by $4.70) and at 20.9x our 2025 EPS estimate of $95.56 (down by...
Research Alert: CFRA Reiterates Strong Sell Opinion On Shares Of Tripadvisor, Inc.
Research Alert: CFRA Reiterates Strong Sell Opinion On Shares Of Tripadvisor, Inc.
Aug 11, 2025
10:15 AM EDT, 08/11/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We raise our 12-month price target by $1 to $13, 10x our 2026 EPS estimate (from 10x our 2025 EPS view). The multiple reflects the extended timeline for TRIP's transformation...
Research Alert: CFRA Retains Hold Opinion On Shares Of 10x Genomics, Inc.
Research Alert: CFRA Retains Hold Opinion On Shares Of 10x Genomics, Inc.
Aug 10, 2025
12:40 AM EDT, 08/11/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We maintain our target price at $12, based on our DCF analysis. We update our 2025 adjusted loss per share (LPS) view to $0.02 (from an LPS of $0.99). We...
Copyright 2023-2026 - www.financetom.com All Rights Reserved